Zofran has become a widely popular morning sickness treatment. Physician expectations were that the anti-nausea drug would benefit the patient, but GlaxoSmithKline, the manufacturer of Zofran, allegedly provided little information on the drug's effect on unborn children. In numerous lawsuits, parents charge that GlaxoSmithKline failed to warn about an association between Zofran and certain very specific birth defects such as cleft palate and heart defects.
Lieff Cabraser attorney Bruce W. Leppla will be speaking at the Investment Company Institute's 2015 Legal Forum "ICI at 75: Facing the Future" on May 7, 2015, in Washington D.C. Leppla will be discussing the topic of investment funds as litigation plaintiffs at this year's legal forum. The Legal Forum invites selected lawyers to give presentations to the investment management industry at the 2015 General Membership Meeting (GMM), the Legal Forum and various other conferences and workshops. Leppla is speaking this year at both the GMM meeting and the Legal Forum. He is the only plaintiffs' lawyer to be invited, and is a frequent speaker at other ICI, International Foundation and NCPERS events.
Roger Heller has been selected by Law360 as a 2015 "Rising Star" in the field of consumer protection. The publication cited Heller's "pivotal role" in securing a wealth of favorable results for plaintiffs challenging deceptive banking and consumer product practices, including a $203 million reinstated class action penalty against Wells Fargo Bank NA, earning him a place among Law360's top three consumer protection attorneys under 40.
Lieff Cabraser attorney Mark P. Chalos will be speaking at the 2015 American Bar Association Section Annual Conference on April 17, 2015 in New Orleans, Louisiana. He will be discussing the topic "When Good Lawyers Go Bad: The Consequences of Lawyer Misconduct and Rambo Tactics During Depositions and at Trial."
Lieff Cabraser attorney Lexi J. Hazam will be discussing the Benicar prescription drug litigation at the 15th Anniversary of the Mass Torts Made Perfect Seminar on April 17, 2015 in Las Vegas, Nevada. Attorneys from across the nation attend the annual conference to learn from leaders of the plaintiffs' bar of the latest developments in lawsuits involving defective and dangerous prescription drugs, medical devices, and other products that collectively have injured tens of thousands of Americans.
Lieff Cabraser attorneys Wendy R. Fleishman and Lexi J. Hazam have been chosen by the American Association for Justice for inclusion in their 2015 Leadership Academy. An initiative of AAJ's Diversity Committee, the Leadership Academy selects 12 plaintiff trial lawyers from different backgrounds and practice areas to develop their leadership roles within AAJ through workshops, training sessions, and conventions.
Lieff Cabraser attorney Lexi Hazam will serve as a panelist at the San Francisco Mass Torts Conference hosted by MCM Services Group. The conference will take place in San Francisco, CA on April 20, 2015. Panelists will provide an introduction and insight to law firms that do not already have a mass torts practice area. Each panelist will go over their experience with mass torts, explain the key litigation stages of a mass tort, and the risks and awards of having a mass tort practice area.
Across the nation, from Seattle to Pittsburgh to North Carolina and Florida, hospital officials have revealed that patients have tested positive for drug-resistant "superbug" bacteria after being examined with a special kind of endoscope, called a duodenoscope. At the same time, some of these same officials assert that they have no evidence the medical scopes at their facility actually transmitted the infections.
Lieff Cabraser represents scores of Type 2 Diabetes patients across America in individual Actos side effects lawsuits. Our clients developed bladder cancer after being prescribed the medication pioglitazone, sold under the brand name Actos.